We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Editorial Comment on Does intensity‐modulated radiation therapy by helical tomotherapy for prostate cancer increase the subsequent risk of bladder cancer? A propensity score‐matched analysis.
- Authors
Ukimura, Osamu
- Abstract
A study by Tsukuda et al. found that 1.87% of patients developed bladder cancer after undergoing intensity-modulated radiation therapy (IMRT) for prostate cancer. In a comparison between IMRT and surgery, the IMRT group had a significantly higher incidence of bladder cancer (2.3%) compared to the surgery group (0.6%). Patients treated with radiotherapy for prostate cancer also had higher rates of bladder and rectal cancer compared to the general population, and those who developed secondary pelvic malignant neoplasms had poorer overall survival. Patients considering radiation therapy should be informed about the risk of secondary bladder cancer, and follow-up should include regular screenings for both low-grade and high-grade cancer. The author of the editorial comment, Osamu Ukimura, has no conflicts of interest.
- Subjects
INTENSITY modulated radiotherapy; RADIOTHERAPY; EDITORIAL writing; BLADDER cancer; DISEASE risk factors; PROSTATE cancer
- Publication
International Journal of Urology, 2024, Vol 31, Issue 4, p385
- ISSN
0919-8172
- Publication type
Article
- DOI
10.1111/iju.15392